CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer

Abstract Development of colorectal cancer (CRC) involves activation of Kirsten rat sarcoma viral oncogene homolog (KRAS) signaling. However, the post-transcriptional regulation of KRAS has yet to be fully characterized. Here, we found that the colorectal neoplasia differentially expressed (CRNDE)/he...

Full description

Bibliographic Details
Main Authors: Ya Lu, Renrui Zou, Quan Gu, Xinyue Wang, Junying Zhang, Rong Ma, Ting Wang, Jianzhong Wu, Jifeng Feng, Yuan Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2023-09-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06137-9
_version_ 1797682623332483072
author Ya Lu
Renrui Zou
Quan Gu
Xinyue Wang
Junying Zhang
Rong Ma
Ting Wang
Jianzhong Wu
Jifeng Feng
Yuan Zhang
author_facet Ya Lu
Renrui Zou
Quan Gu
Xinyue Wang
Junying Zhang
Rong Ma
Ting Wang
Jianzhong Wu
Jifeng Feng
Yuan Zhang
author_sort Ya Lu
collection DOAJ
description Abstract Development of colorectal cancer (CRC) involves activation of Kirsten rat sarcoma viral oncogene homolog (KRAS) signaling. However, the post-transcriptional regulation of KRAS has yet to be fully characterized. Here, we found that the colorectal neoplasia differentially expressed (CRNDE)/heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) axis was notably elevated in CRC and was strongly associated with poor prognosis of patients, while also significantly promoting CRC cell proliferation and metastasis both in vitro and in vivo. Furthermore, CRNDE maintained the stability of hnRNPA2B1 protein by inhibiting E3 ubiquitin ligase TRIM21 mediated K63 ubiquitination-dependent protein degradation. CRNDE/hnRNPA2B1 axis facilitated the nuclear export and translation of KRAS mRNA, which specifically activated the MAPK signaling pathway, eventually accelerating the malignant progression of CRC. Our findings provided insight into the regulatory network for stable hnRNPA2B1 protein expression, and the molecular mechanisms by which the CRNDE/hnRNPA2B1 axis mediated KRAS nucleocytoplasmic transport and translation, deeply underscoring the bright future of hnRNPA2B1 as a promising biomarker and therapeutic target for CRC. By hindering hnRNPA2B1 from binding to the E3 ubiquitin ligase TRIM21, whose mediated ubiquitin-dependent degradation was thereby inhibited, CRNDE protected the stability of hnRNPA2B1’s high protein expression in CRC. Supported by the high level of the oncogenic molecule CRNDE, hnRNPA2B1 bound to KRAS mRNA and promoted KRAS mRNA nucleus export to enter the ribosomal translation program, subsequently activating the MAPK signaling pathway and ultimately accelerating the malignant progression of CRC.
first_indexed 2024-03-12T00:02:29Z
format Article
id doaj.art-bf413aec7f464c5da3f1de7fe37c5c20
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-12T00:02:29Z
publishDate 2023-09-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-bf413aec7f464c5da3f1de7fe37c5c202023-09-17T11:29:21ZengNature Publishing GroupCell Death and Disease2041-48892023-09-0114911210.1038/s41419-023-06137-9CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancerYa Lu0Renrui Zou1Quan Gu2Xinyue Wang3Junying Zhang4Rong Ma5Ting Wang6Jianzhong Wu7Jifeng Feng8Yuan Zhang9Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityResearch Center of Clinical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityDepartment of Cell Biology, School of Basic Medical Sciences, Nanjing Medical UniversityResearch Center of Clinical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical UniversityAbstract Development of colorectal cancer (CRC) involves activation of Kirsten rat sarcoma viral oncogene homolog (KRAS) signaling. However, the post-transcriptional regulation of KRAS has yet to be fully characterized. Here, we found that the colorectal neoplasia differentially expressed (CRNDE)/heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) axis was notably elevated in CRC and was strongly associated with poor prognosis of patients, while also significantly promoting CRC cell proliferation and metastasis both in vitro and in vivo. Furthermore, CRNDE maintained the stability of hnRNPA2B1 protein by inhibiting E3 ubiquitin ligase TRIM21 mediated K63 ubiquitination-dependent protein degradation. CRNDE/hnRNPA2B1 axis facilitated the nuclear export and translation of KRAS mRNA, which specifically activated the MAPK signaling pathway, eventually accelerating the malignant progression of CRC. Our findings provided insight into the regulatory network for stable hnRNPA2B1 protein expression, and the molecular mechanisms by which the CRNDE/hnRNPA2B1 axis mediated KRAS nucleocytoplasmic transport and translation, deeply underscoring the bright future of hnRNPA2B1 as a promising biomarker and therapeutic target for CRC. By hindering hnRNPA2B1 from binding to the E3 ubiquitin ligase TRIM21, whose mediated ubiquitin-dependent degradation was thereby inhibited, CRNDE protected the stability of hnRNPA2B1’s high protein expression in CRC. Supported by the high level of the oncogenic molecule CRNDE, hnRNPA2B1 bound to KRAS mRNA and promoted KRAS mRNA nucleus export to enter the ribosomal translation program, subsequently activating the MAPK signaling pathway and ultimately accelerating the malignant progression of CRC.https://doi.org/10.1038/s41419-023-06137-9
spellingShingle Ya Lu
Renrui Zou
Quan Gu
Xinyue Wang
Junying Zhang
Rong Ma
Ting Wang
Jianzhong Wu
Jifeng Feng
Yuan Zhang
CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
Cell Death and Disease
title CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
title_full CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
title_fullStr CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
title_full_unstemmed CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
title_short CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer
title_sort crnde mediated hnrnpa2b1 stability facilitates nuclear export and translation of kras in colorectal cancer
url https://doi.org/10.1038/s41419-023-06137-9
work_keys_str_mv AT yalu crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT renruizou crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT quangu crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT xinyuewang crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT junyingzhang crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT rongma crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT tingwang crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT jianzhongwu crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT jifengfeng crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer
AT yuanzhang crndemediatedhnrnpa2b1stabilityfacilitatesnuclearexportandtranslationofkrasincolorectalcancer